VRTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $36,816,298.16

Vertex Pharmaceuticals Insider Trading History Chart

Vertex Pharmaceuticals Share Price & Price History

^$483.96

▼ -10.65 (-2.15%)

As of 11/14/2024 01:00 AM ET

Days: 30 | 90 | 365

The next assassination attempt won’t be on Trump

From Porter & Company | Ad

President Trump is soon to be back in the White House. Unity has been restored to the U.S. But if you watched the President’s 25-minute victory speech, you probably noticed he spent nearly four minutes speaking about one very controversial person.

I share with you in this special investigative documentary.

Vertex Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/30/2024	Jeffrey M. Leiden	Chairman	Sell	3,784	$499.00	$1,888,216.00	9,994
8/30/2024	Sangeeta N Bhatia	Director	Sell	646	$500.00	$323,000.00	4,435
8/7/2024	Carmen Bozic	CMO	Sell	2,280	$476.75	$1,086,990.00	23,259
8/1/2024	Bruce I. Sachs	Director	Sell	5,295	$508.00	$2,689,860.00	40,000
7/24/2024	Carmen Bozic	CMO	Sell	2,280	$488.46	$1,113,688.80	25,539
7/22/2024	Reshma Kewalramani	CEO	Sell	15,202	$497.00	$7,555,394.00	106,172
7/10/2024	Carmen Bozic	CMO	Sell	2,280	$487.34	$1,111,135.20	27,819
6/26/2024	Carmen Bozic	CMO	Sell	2,280	$471.72	$1,075,521.60	30,099
6/12/2024	Carmen Bozic	CMO	Sell	2,280	$478.00	$1,089,840.00	32,379
6/12/2024	E. Morrey Atkinson, III	EVP	Sell	7,288	$478.00	$3,483,664.00	15,972
5/30/2024	Ourania Tatsis	EVP	Sell	2,350	$439.11	$1,031,908.50	53,523
5/29/2024	Carmen Bozic	CMO	Sell	2,280	$445.56	$1,015,876.80	34,659
5/28/2024	Charles F. Wagner, Jr.	CFO	Sell	3,250	$454.79	$1,478,067.50	50,387
5/24/2024	Reshma Kewalramani	CEO	Sell	1,565	$457.00	$715,205.00	121,374
5/22/2024	Bruce I. Sachs	Director	Sell	7,073	$448.00	$3,168,704.00	40,000
2/26/2024	Ourania Tatsis	EVP	Sell	354	$425.70	$150,697.80	55,804
2/20/2024	Ourania Tatsis	EVP	Sell	480	$420.79	$201,979.20	59,827
2/12/2024	Amit Sachdev	EVP	Sell	3,222	$420.24	$1,354,013.28	74,364
2/12/2024	Jeffrey M. Leiden	Chairman	Sell	2,656	$419.51	$1,114,218.56	27,644
2/12/2024	Kristen Ambrose	CAO	Sell	1,374	$420.24	$577,409.76	9,676
2/12/2024	Stuart A. Arbuckle	COO	Sell	4,295	$420.24	$1,804,930.80	75,718
1/8/2024	Jeffrey M. Leiden	Chairman	Sell	6,648	$419.07	$2,785,977.36	2,423
11/6/2023	Bruce I. Sachs	Director	Sell	11,250	$385.00	$4,331,250.00	40,000
10/31/2023	Carmen Bozic	CMO	Sell	5,651	$355.92	$2,011,303.92	34,952
10/17/2023	Carmen Bozic	CMO	Sell	5,651	$373.25	$2,109,235.75	40,603
10/17/2023	Sangeeta N Bhatia	Director	Sell	243	$375.00	$91,125.00	3,901
10/16/2023	Jeffrey M. Leiden	Chairman	Sell	12,962	$374.00	$4,847,788.00	22,425
10/6/2023	Sangeeta N Bhatia	Director	Sell	242	$360.00	$87,120.00	4,144
10/3/2023	Carmen Bozic	CMO	Sell	5,651	$345.28	$1,951,177.28	46,254
10/2/2023	Jonathan Biller	EVP	Sell	610	$346.76	$211,523.60	10,569
9/19/2023	Carmen Bozic	CMO	Sell	5,651	$351.00	$1,983,501.00	51,905
8/23/2023	Ourania Tatsis	EVP	Sell	2,500	$355.00	$887,500.00	48,637
8/9/2023	David Altshuler	EVP	Sell	63	$345.51	$21,767.13	32,038
8/9/2023	Sangeeta N Bhatia	Director	Sell	242	$345.51	$83,613.42	4,386
7/17/2023	Bruce I. Sachs	Director	Sell	11,250	$356.75	$4,013,437.50	40,000
7/17/2023	Reshma Kewalramani	CEO	Sell	7,828	$355.00	$2,778,940.00	118,906
6/15/2023	Stuart A. Arbuckle	COO	Sell	8,603	$349.00	$3,002,447.00	56,556
5/30/2023	Kristen Ambrose	CAO	Sell	289	$329.82	$95,317.98	6,838
5/30/2023	Stuart A. Arbuckle	COO	Sell	82	$329.82	$27,045.24	56,556
5/8/2023	Bastiano Sanna	EVP	Sell	2,850	$350.00	$997,500.00	32,038
5/8/2023	Jeffrey M. Leiden	Chairman	Sell	1,125	$349.00	$392,625.00	35,387
5/5/2023	Bastiano Sanna	EVP	Sell	422	$350.03	$147,712.66	34,888
5/5/2023	Jeffrey M. Leiden	Chairman	Sell	879	$349.56	$307,263.24	36,512
5/2/2023	Bastiano Sanna	EVP	Sell	1,622	$350.66	$568,770.52	38,091
5/2/2023	Jeffrey M. Leiden	Chairman	Sell	6,450	$349.89	$2,256,790.50	41,899
5/2/2023	Sangeeta N Bhatia	Director	Sell	580	$348.28	$202,002.40	4,628
4/27/2023	Reshma Kewalramani	CEO	Sell	3,317	$339.08	$1,124,728.36	126,652
4/12/2023	Bastiano Sanna	EVP	Sell	7,567	$326.70	$2,472,138.90	39,713
4/12/2023	Bruce I. Sachs	Director	Sell	21,300	$326.73	$6,959,349.00	41,210
4/4/2023	Bastiano Sanna	EVP	Sell	522	$315.81	$164,852.82	47,280
3/24/2023	Charles F. Wagner, Jr.	CFO	Sell	1,768	$305.38	$539,911.84	49,611
3/17/2023	Charles F. Wagner, Jr.	CFO	Sell	2,000	$296.39	$592,780.00	51,379
3/16/2023	Bastiano Sanna	EVP	Sell	2,746	$300.59	$825,420.14	49,268
3/13/2023	Charles F. Wagner, Jr.	CFO	Sell	2,666	$293.83	$783,350.78	53,379
3/10/2023	Charles F. Wagner, Jr.	CFO	Sell	2,088	$289.61	$604,705.68	56,045
2/27/2023	Kristen Ambrose	CAO	Sell	1,207	$287.55	$347,072.85	7,303
2/27/2023	Ourania Tatsis	EVP	Sell	354	$287.48	$101,767.92	56,805
2/27/2023	Stuart A. Arbuckle	COO	Sell	5,034	$287.47	$1,447,123.98	56,556
2/22/2023	Stuart A. Arbuckle	COO	Sell	2,401	$294.33	$706,686.33	66,304
2/13/2023	Ourania Tatsis	EVP	Sell	275	$298.99	$82,222.25	65,765
2/13/2023	Stuart A. Arbuckle	COO	Sell	4,887	$298.92	$1,460,822.04	82,003
2/6/2023	David Altshuler	EVP	Sell	1,304	$306.00	$399,024.00	68,645
1/30/2023	Lloyd Carney	Director	Sell	2,700	$320.52	$865,404.00	4,150
1/27/2023	Yuchun Lee	Director	Sell	1,429	$322.03	$460,180.87	1,875
1/25/2023	Reshma Kewalramani	CEO	Sell	10,000	$315.05	$3,150,500.00	89,598
1/25/2023	Yuchun Lee	Director	Sell	4,000	$313.96	$1,255,840.00	1,875
1/23/2023	Yuchun Lee	Director	Sell	2,129	$312.02	$664,290.58	1,875
1/18/2023	Yuchun Lee	Director	Sell	442	$312.17	$137,979.14	1,875
11/7/2022	David Altshuler	EVP	Sell	1,303	$303.04	$394,861.12	36,077
10/24/2022	Sangeeta N Bhatia	Director	Sell	621	$310.00	$192,510.00	4,040
10/18/2022	Bastiano Sanna	EVP	Sell	1,791	$300.31	$537,855.21	39,192
8/15/2022	Joy Liu	SVP	Sell	3,747	$303.90	$1,138,713.30	9,605
8/15/2022	Reshma Kewalramani	CEO	Sell	11,689	$305.06	$3,565,846.34	99,598
8/15/2022	Stuart A. Arbuckle	COO	Sell	22,173	$303.93	$6,739,039.89	45,278
8/9/2022	Joy Liu	SVP	Sell	946	$300.00	$283,800.00	13,388
8/9/2022	Ourania Tatsis	EVP	Sell	1,400	$298.97	$418,558.00	46,090
8/9/2022	Stuart A. Arbuckle	COO	Sell	5,690	$300.67	$1,710,812.30	60,996
8/8/2022	Sangeeta N Bhatia	Director	Sell	621	$293.03	$181,971.63	4,661
7/29/2022	Sangeeta N Bhatia	Director	Sell	621	$278.77	$173,116.17	5,282
7/25/2022	Jeffrey M. Leiden	Chairman	Sell	132,079	$281.38	$37,164,389.02	2,423
7/19/2022	David Altshuler	EVP	Sell	17,865	$288.65	$5,156,732.25	36,077
6/24/2022	Reshma Kewalramani	CEO	Sell	11,689	$291.30	$3,405,005.70	111,153
5/4/2022	Bastiano Sanna	EVP	Sell	36	$275.09	$9,903.24	41,660
5/2/2022	Bastiano Sanna	EVP	Sell	320	$259.16	$82,931.20	41,696
5/2/2022	Charles F. Wagner, Jr.	CFO	Sell	343	$258.83	$88,778.69	42,730
5/2/2022	Sangeeta N Bhatia	Director	Sell	737	$258.94	$190,838.78	5,903
5/2/2022	Stuart A. Arbuckle	COO	Sell	306	$263.98	$80,777.88	64,760
4/29/2022	Joy Liu	SVP	Sell	120	$275.41	$33,049.20	14,334
4/25/2022	Kristen Ambrose	CAO	Sell	327	$269.55	$88,142.85	3,496
4/18/2022	Yuchun Lee	Director	Sell	2,000	$284.23	$568,460.00	1,875
4/13/2022	Jeffrey M. Leiden	Chairman	Sell	15,789	$289.04	$4,563,652.56	74,160
4/13/2022	Yuchun Lee	Director	Sell	2,000	$287.50	$575,000.00	1,875
4/11/2022	Yuchun Lee	Director	Sell	2,000	$280.30	$560,600.00	1,875
4/7/2022	Bastiano Sanna	EVP	Sell	561	$276.18	$154,936.98	42,782
4/7/2022	Yuchun Lee	Director	Sell	2,000	$274.86	$549,720.00	1,099
4/4/2022	Bastiano Sanna	EVP	Sell	562	$267.71	$150,453.02	43,343
4/4/2022	Yuchun Lee	Director	Sell	2,000	$267.72	$535,440.00	1,875
4/1/2022	Charles F. Wagner, Jr.	CFO	Sell	2,582	$264.76	$683,610.32	43,620
3/31/2022	Margaret G. McGlynn	Director	Sell	5,000	$262.27	$1,311,350.00	1,099
3/17/2022	Charles F. Wagner, Jr.	CFO	Sell	3,171	$250.15	$793,225.65
3/17/2022	Ourania Tatsis	EVP	Sell	2,833	$250.11	$708,561.63
2/25/2022	Ourania Tatsis	EVP	Sell	325	$230.95	$75,058.75
2/18/2022	Ourania Tatsis	EVP	Sell	519	$231.00	$119,889.00
2/11/2022	David Altshuler	EVP	Sell	2,297	$235.02	$539,840.94
2/2/2022	Bastiano Sanna	EVP	Sell	1,040	$250.98	$261,019.20
2/2/2022	Charles F. Wagner, Jr.	CFO	Sell	2,944	$250.07	$736,206.08
1/28/2022	Margaret G. McGlynn	Director	Sell	5,000	$241.79	$1,208,950.00
11/15/2021	Amit Sachdev	EVP	Sell	51	$187.19	$9,546.69
11/15/2021	Stuart A. Arbuckle	COO	Sell	3	$187.26	$561.78

“This Changes Everything” - Trump Hands Millions Massive IRS Gift

From Colonial Metals | Ad

Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…

>> YES! Send Me My FREE Gold Guide!

SEC Filings (Institutional Ownership Changes) for Vertex Pharmaceuticals (NASDAQ:VRTX)

90.96% of Vertex Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vertex Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/14/2024	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	43,058	$20.03M	0.1%	-13.0%	0.017%
11/14/2024	Edgestream Partners L.P.	2,202	$1.02M	0.0%	-17.4%	0.001%
11/14/2024	Caisse DE Depot ET Placement DU Quebec	371,969	$173M	0.3%	-33.1%	0.144%
11/14/2024	Fred Alger Management LLC	18,035	$8.39M	0.0%	-70.0%	0.007%
11/14/2024	Captrust Financial Advisors	14,409	$6.70M	0.0%	+2.2%	0.006%
11/14/2024	Atlantic Union Bankshares Corp	7,558	$3.52M	0.2%	+4.6%	0.003%
11/14/2024	Icon Wealth Advisors LLC	2,403	$1.12M	0.1%	+3.6%	0.001%
11/14/2024	Rockefeller Capital Management L.P.	70,549	$32.81M	0.1%	-0.9%	0.027%
11/14/2024	Martingale Asset Management L P	53,327	$24.80M	0.6%	-14.9%	0.021%
11/14/2024	Hantz Financial Services Inc.	3,544	$1.65M	0.0%	+2.0%	0.001%
11/14/2024	Northwest & Ethical Investments L.P.	26,640	$12.39M	0.3%	+10.8%	0.010%
11/14/2024	Vinva Investment Management Ltd	2,443	$1.13M	0.0%	-73.5%	0.001%
11/14/2024	Public Sector Pension Investment Board	11,244	$5.23M	0.0%	+14.2%	0.004%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	2,441,468	$1.14B	0.3%	-5.5%	0.948%
11/14/2024	Fiduciary Trust Co	12,013	$5.59M	0.1%	+22.2%	0.005%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	320,144	$148.89M	0.4%	-17.7%	0.124%
11/14/2024	FORA Capital LLC	9,402	$4.37M	0.5%	+15.0%	0.004%
11/14/2024	True Vision MN LLC	943	$0.44M	0.3%	-9.7%	0.000%
11/14/2024	MetLife Investment Management LLC	73,011	$33.96M	0.2%	-2.4%	0.028%
11/14/2024	CreativeOne Wealth LLC	7,475	$3.48M	0.1%	+76.6%	0.003%
11/14/2024	BNP Paribas	5,653	$2.63M	0.1%	-4.8%	0.002%
11/14/2024	Healthcare of Ontario Pension Plan Trust Fund	49,065	$22.82M	0.1%	+107.1%	0.019%
11/14/2024	Cravens & Co Advisors LLC	2,208	$1.03M	0.8%	-3.0%	0.001%
11/13/2024	Glenmede Trust Co. NA	4,093	$1.90M	0.0%	-96.9%	0.002%
11/13/2024	Bridgewater Associates LP	3,452	$1.61M	0.0%	-89.6%	0.001%
11/13/2024	Freedom Investment Management Inc.	4,714	$2.19M	0.2%	+3.7%	0.002%
11/13/2024	Cynosure Group LLC	893	$0.42M	0.1%	-41.9%	0.000%
11/13/2024	Townsquare Capital LLC	15,054	$7M	0.1%	+31.6%	0.006%
11/13/2024	Baldwin Investment Management LLC	11,891	$5.53M	0.7%	+1.1%	0.005%
11/13/2024	Transamerica Financial Advisors Inc.	8,174	$3.80M	0.4%	+1,673.1%	0.003%
11/13/2024	Principal Street Partners LLC	3,010	$1.41M	0.2%	+26.4%	0.001%
11/13/2024	Avestar Capital LLC	3,156	$1.47M	0.2%	+3.4%	0.001%
11/13/2024	Brooklyn Investment Group	1,873	$0.87M	0.3%	+4.9%	0.001%
11/13/2024	D.A. Davidson & CO.	5,475	$2.55M	0.0%	+12.6%	0.002%
11/13/2024	FMR LLC	10,525,013	$4.89B	0.3%	-1.9%	4.087%
11/13/2024	Dai ichi Life Insurance Company Ltd	26,093	$12.14M	0.3%	-13.9%	0.010%
11/13/2024	The Manufacturers Life Insurance Company	622,225	$289.38M	0.3%	-1.8%	0.242%
11/13/2024	Qsemble Capital Management LP	1,264	$0.59M	0.1%	+68.3%	0.000%
11/13/2024	Bank of Montreal Can	557,217	$257.93M	0.1%	+9.0%	0.216%
11/13/2024	Associated Banc Corp	9,119	$4.24M	0.1%	-3.8%	0.004%
11/13/2024	Private Trust Co. NA	964	$0.45M	0.0%	-16.5%	0.000%
11/13/2024	Hancock Whitney Corp	2,708	$1.26M	0.0%	-2.8%	0.001%
11/13/2024	Truvestments Capital LLC	76	$35K	0.0%	N/A	0.000%
11/13/2024	Brown Brothers Harriman & Co.	2,478	$1.15M	0.0%	-1.0%	0.001%
11/13/2024	Loomis Sayles & Co. L P	3,068,214	$1.43B	1.9%	-2.4%	1.191%
11/13/2024	Boston Family Office LLC	566	$0.26M	0.0%	N/A	0.000%
11/13/2024	Independent Advisor Alliance	1,174	$0.55M	0.0%	-35.2%	0.000%
11/13/2024	Harvest Fund Management Co. Ltd	11,918	$5.54M	0.3%	-0.8%	0.005%
11/13/2024	Douglass Winthrop Advisors LLC	918	$0.43M	0.0%	-2.5%	0.000%
11/13/2024	Fisher Asset Management LLC	27,022	$12.57M	0.0%	-3.9%	0.010%
11/13/2024	Daiwa Securities Group Inc.	57,867	$26.91M	0.1%	+32.5%	0.022%
11/12/2024	Hartford Funds Management Co LLC	1,075	$0.50M	0.0%	+4.1%	0.000%
11/12/2024	Summit Trail Advisors LLC	3,264	$1.52M	0.0%	+13.3%	0.001%
11/12/2024	Draper Asset Management LLC	6,300	$2.93M	2.1%	+10.9%	0.002%
11/12/2024	Westfield Capital Management Co. LP	1,272	$0.59M	0.0%	+133.8%	0.000%
11/12/2024	Centaurus Financial Inc.	1,858	$0.86M	0.1%	+18.4%	0.001%
11/12/2024	Crewe Advisors LLC	563	$0.26M	0.0%	+8.3%	0.000%
11/12/2024	Larson Financial Group LLC	417	$0.19M	0.0%	+21.9%	0.000%
11/12/2024	Pitcairn Co.	2,094	$0.97M	0.1%	-2.1%	0.001%
11/12/2024	Cerity Partners LLC	229,042	$106.52M	0.2%	+14.6%	0.089%
11/12/2024	Great Valley Advisor Group Inc.	18,250	$8.49M	0.2%	+23.4%	0.007%
11/12/2024	Nicolet Advisory Services LLC	641	$0.29M	0.0%	+4.6%	0.000%
11/12/2024	Camden National Bank	21,124	$9.82M	1.4%	-0.9%	0.008%
11/12/2024	Icon Wealth Advisors LLC	20,608	$9.58M	0.4%	+788.3%	0.008%
11/12/2024	Covenant Asset Management LLC	12,764	$5.94M	0.9%	+0.9%	0.005%
11/12/2024	STF Management LP	3,701	$1.72M	0.8%	-10.2%	0.001%
11/12/2024	Raymond James Trust N.A.	3,829	$1.78M	0.0%	-5.7%	0.001%
11/12/2024	Edgewood Management LLC	1,546,370	$719.19M	1.9%	+7,876.3%	0.600%
11/12/2024	Eagle Asset Management Inc.	8,119	$4.20M	0.0%	+21.6%	0.003%
11/12/2024	HealthInvest Partners AB	16,993	$7.90M	3.7%	+12.6%	0.007%
11/12/2024	Charles Schwab Investment Management Inc.	1,626,347	$756.38M	0.1%	+1.3%	0.632%
11/12/2024	Banco Santander S.A.	15,868	$7.38M	0.1%	-3.4%	0.006%
11/12/2024	Navellier & Associates Inc.	11,032	$5.13M	0.7%	-5.7%	0.004%
11/12/2024	L & S Advisors Inc	3,217	$1.50M	0.2%	-7.6%	0.001%
11/12/2024	Mizuho Securities USA LLC	16,737	$7.78M	0.2%	-15.9%	0.006%
11/12/2024	DE Burlo Group Inc.	49,195	$22.88M	2.8%	+1.3%	0.019%
11/12/2024	Pacer Advisors Inc.	32,441	$15.09M	0.0%	-15.4%	0.013%
11/12/2024	Massachusetts Financial Services Co. MA	2,905,705	$1.35B	0.4%	+5.8%	1.128%
11/12/2024	Integrated Investment Consultants LLC	19,734	$9.18M	0.2%	N/A	0.008%
11/9/2024	Trustmark National Bank Trust Department	6,466	$3.01M	0.2%	+5.9%	0.003%
11/9/2024	Cypress Capital Group	1,278	$0.59M	0.1%	-6.4%	0.000%
11/9/2024	Intech Investment Management LLC	17,713	$8.24M	0.1%	-7.8%	0.007%
11/8/2024	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	396,019	$184.18M	0.5%	-2.8%	0.154%
11/8/2024	Cornerstone Advisors LLC	13,000	$6.05M	0.2%	+6.6%	0.005%
11/8/2024	Citizens Financial Group Inc. RI	22,117	$10.29M	0.2%	-25.0%	0.009%
11/8/2024	Moran Wealth Management LLC	29,078	$13.52M	0.4%	+1.6%	0.011%
11/8/2024	Moors & Cabot Inc.	3,578	$1.66M	0.1%	-4.3%	0.001%
11/8/2024	EagleClaw Capital Managment LLC	7,625	$3.55M	0.6%	+2.7%	0.003%
11/8/2024	Grandfield & Dodd LLC	14,144	$6.58M	0.4%	+21.9%	0.005%
11/8/2024	Portfolio Design Labs LLC	4,579	$2.13M	0.6%	+123.0%	0.002%
11/8/2024	EULAV Asset Management	31,500	$14.65M	0.4%	-12.5%	0.012%
11/8/2024	First Horizon Advisors Inc.	2,163	$1.01M	0.0%	-1.2%	0.001%
11/8/2024	Advisors Asset Management Inc.	26,467	$12.31M	0.2%	+14.5%	0.010%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	7,831	$3.64M	0.0%	-88.4%	0.003%
11/8/2024	Howe & Rusling Inc.	9,092	$4.23M	0.4%	+3.6%	0.004%
11/8/2024	Jennison Associates LLC	5,550,386	$2.58B	1.6%	+18.1%	2.155%
11/8/2024	Commerce Bank	7,443	$3.46M	0.0%	+11.6%	0.003%
11/8/2024	MWA Asset Management	2,583	$1.20M	0.8%	-43.9%	0.001%
11/8/2024	Northwest Bancshares Inc.	13,125	$6.10M	1.0%	-17.0%	0.005%
11/8/2024	Strategy Asset Managers LLC	2,709	$1.26M	0.2%	-40.0%	0.001%

Data available starting January 2016

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age or older; SYMDEKO/SYMKEVI for people with CF for 6 years of age or older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 year or older who have CF with ivacaftor. The company's pipeline includes VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1 clinical trial; VX-548, a non-opioid medicine for the treatment of acute and neuropathic pain which is in Phase 3 clinical trial; Exa-cel, for the treatment of sickle cell disease and transfusion-dependent beta thalassemia which is in Phase 2/3 clinical trial. In addition, it provides inaxaplin for the treatment of APOL1-mediated focal segmental glomerulosclerosis and co-morbidities, such as hypertension which is in single Phase 2/3; VX- 880 and VX-264, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-970, which is in Phase 2 clinical trial for the treatment of cancer; and VX-803 and VX-984 for treatment of cancer in Phase 1 clinical trial. Further, it sells the products to specialty pharmacy and specialty distributors in the United States, as well as retail pharmacies, hospitals, and clinics. Additionally, the company has collaborations with CRISPR Therapeutics AG.; Moderna, Inc.; Entrada Therapeutics, Inc.; Arbor Biotechnologies, Inc.; Mammoth Biosciences, Inc.; and Verve Therapeutics., as well as collaborations with Tevard Biosciences to develop novel tRNA-based therapies for duchenne muscular dystrophy. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $483.96

$483.56

$495.62

50 Day Range

MA: $476.13

$448.60

$516.74

52 Week Range

Now: $483.96

$341.90

$519.88

Volume

1,231,531 shs

Average Volume

1,173,140 shs

Market Capitalization

$124.63 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.39

Who are the company insiders with the largest holdings of Vertex Pharmaceuticals?: Vertex Pharmaceuticals' top insider shareholders include:
Reshma Kewalramani (CEO)
Stuart A Arbuckle (COO)
Amit Sachdev (EVP)
David Altshuler (EVP)
Ourania Tatsis (EVP)
Charles F Wagner Jr (CFO)
Carmen Bozic (CMO)
Bastiano Sanna (EVP)
Jeffrey M Leiden (Chairman)
Bruce I Sachs (Director)
Edward Morrow Atkinson III (EVP)
Jonathan Biller (EVP)
Kristen Ambrose (CAO)
Sangeeta N Bhatia (Director)
Lloyd Carney (Director)
Yuchun Lee (Director)
Learn More about top insider investors at Vertex Pharmaceuticals.
Who are the major institutional investors of Vertex Pharmaceuticals?: Vertex Pharmaceuticals' top institutional investors include:
FMR LLC — 4.09%
Jennison Associates LLC — 2.16%
Loomis Sayles & Co. L P — 1.19%
Massachusetts Financial Services Co. MA — 1.13%
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 0.95%
Charles Schwab Investment Management Inc. — 0.63%
Learn More about top institutional investors of Vertex Pharmaceuticals stock.
Which major investors are selling Vertex Pharmaceuticals stock?: Within the previous quarter, VRTX stock was sold by these institutional investors:
Mayflower Financial Advisors LLC
AMF Tjanstepension AB
FMR LLC
Caisse DE Depot ET Placement DU Quebec
Assetmark Inc.
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Glenmede Trust Co. NA
Swedbank AB
In the last year, company insiders that have sold Vertex Pharmaceuticals company stock include:
Reshma Kewalramani (CEO)
Stuart A Arbuckle (COO)
Amit Sachdev (EVP)
David Altshuler (EVP)
Ourania Tatsis (EVP)
Charles F Wagner Jr (CFO)
Carmen Bozic (CMO)
Bastiano Sanna (EVP)
Jeffrey M Leiden (Chairman)
Bruce I Sachs (Director)
Edward Morrow Atkinson III (EVP)
Learn More investors selling Vertex Pharmaceuticals stock.
Which major investors are buying Vertex Pharmaceuticals stock?: During the previous quarter, VRTX stock was acquired by institutional investors including:
Edgewood Management LLC
Jennison Associates LLC
International Assets Investment Management LLC
AustralianSuper Pty Ltd
Assenagon Asset Management S.A.
Massachusetts Financial Services Co. MA
Walleye Trading LLC
Segall Bryant & Hamill LLC